Antivirus immune activity in multiple sclerosis correlates with MRI activity

Area of Science:

• Neuroimmunology
• Viral Immunology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• The role of viral infections, particularly Epstein-Barr virus (EBV), in MS pathogenesis is under investigation.

Purpose of the Study:

• To investigate the correlation between Epstein-Barr virus (EBV) reactivation or anti-EBV immune response and MS disease activity.
• To assess if immune responses to EBV predict future MS lesions on MRI.

Main Methods:

• Longitudinal study of 20 early, active relapsing-remitting MS patients over 16 weeks.
• Regular blood and saliva sampling for immune response assays (proliferation, ELISPOT) and viral DNA quantification (qPCR).
• Serial brain MRI scans to quantify new and enhancing lesions.

Main Results:

• A significant correlation was found between T-cell proliferation to autologous EBV-infected lymphoblastoid cell lines (LCL) and the number of active MRI lesions 4 weeks later.
• Both proliferation and interferon-γ secretion in response to LCL correlated with the number of enhancing lesions 8 weeks later.

Conclusions:

• Antiviral immune responses in peripheral blood are associated with subsequent MS disease activity.
• These findings suggest a potential role for EBV-specific immune responses in predicting MS relapses.